ALBIREO PHARMA, INC. — Net Income by Fiscal Year

18 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/ad1198cb-280f-4bc8-9230-d42b4a5df2a7/serie/net-income

Fiscal year	Net Income	Period	Evidence
FY 2021	$-34.0M	2021-01-01 – 2021-12-31	evidence 0001558370-22-002501
FY 2020	$-107.6M	2020-01-01 – 2020-12-31	evidence 0001558370-21-001730
FY 2019	$-62.7M	2019-01-01 – 2019-12-31	evidence 0001558370-20-001905
FY 2018	$-46.1M	2018-01-01 – 2018-12-31	evidence 0001558370-19-001601
FY 2017	$-24.4M	2017-01-01 – 2017-12-31	evidence 0001564590-18-006847
FY 2016	$-16.4M	2016-01-01 – 2016-12-31	evidence 0001564590-17-005341
FY 2015	$-6.8M	2015-01-01 – 2015-12-31	evidence 0001564590-17-005341
FY 2014	$-14.1M	2013-10-01 – 2014-09-30	evidence 0001145443-14-001571
FY 2013	$-219.0M	2003-12-04 – 2014-03-31	evidence 0001145443-14-000763
FY 2012	$-199.9M	2003-12-04 – 2013-03-31	evidence 0001145443-13-001314
FY 2011	$-179.1M	2003-12-03 – 2012-03-31	evidence 0001145443-12-000728
FY 2010	$-38.3M	2009-10-01 – 2010-09-30	evidence 0001145443-11-001243
FY 2009	$-43.3M	2008-10-01 – 2009-09-30	evidence 0001145443-11-001243
FY 2008	$-43.4M	2007-10-01 – 2008-09-30	evidence 0001145443-11-001243
FY 2007	$-22.5M	2006-10-01 – 2007-09-30	evidence 0001145443-11-001243
FY 2006	$-8.1M	2005-10-01 – 2006-09-30	evidence 0001145443-11-001243
FY 2005	$-3.4M	2004-10-01 – 2005-09-30	evidence 0001145443-11-001243
FY 2004	$-774.0k	2003-12-04 – 2004-09-30	evidence 0001145443-12-001417

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

ALBIREO PHARMA, INC. — all facts · Revenue · Operating Income